NextSeq 500: What will you do next?

14 January 2014

Since the launch of Illumina's first next-generation DNA sequencing system in 2007 the pace of innovation in genomics has been breathtaking. The breakthrough scientific advancements our customer have made are amazing. The next evolution in sequencing is now available, NextSeq 500 will transform your research, enable new discoveries and empower you to stay a step ahead. What will you do next?

Share this article on    
    
For Research Use Only

Not for use in diagnostic procedures (except as specifically noted).

Innovative technologies

At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.

All trademarks are the property of Illumina, Inc. or their respective owners.
For specific trademark information, see emea.illumina.com/company/legal.html.

© 2024 Illumina, Inc. All rights reserved.